Humacyte Inc’s profitability metrics reveal strong financial health. The company currently boasts an operating margin of 0.00% with a gross margin of 86.22%. The profit margin, also known as the ...

TD Cowen analyst Josh Jennings maintained a Buy rating on Humacyte (HUMA – Research Report) today and set a price target of $10.00. The ...

Piper Sandler analyst Allison Bratzel maintained a Hold rating on Humacyte (HUMA – Research Report) today and set a price target of ...

Check the time stamp on this data. Updated AI-Generated Signals for Humacyte Inc. (HUMA) available here: HUMA.

In the latest market close, Humacyte, Inc. (HUMA) reached $5.70, with a +0.53% movement compared to the previous day. This change outpaced the S&P 500's 0.76% loss on the day. Meanwhile, the Dow lost ...

On Friday, Humacyte Inc (HUMA) stock saw a modest uptick, ending the day at $5.73 which represents a slight increase of $0.18 or 3.24% from the prior close of $5.55. The stock opened at $5.49 and ...

As of 3:20 PM EDT. Market Open. DURHAM, N.C., Oct. 08, 2024 (GLOBE NEWSWIRE) -- Humacyte, Inc. (Nasdaq: HUMA), a clinical-stage biotechnology platform company ...

London-based scaleup Huma announced today the expansion of its digital healthcare solutions with the acquisition of eConsult.

Huma Qureshi wraps up the shoot for Director Vipul Mehta's Gulabi, starring Parambrata Chattopadhyay, Dibyendu Bhattacharya ...

Huma Qureshi, who is all set to appear in her next film 'Gulabi' gave fans an exciting update by announcing that the movie's ...

Huma Qureshi has just completed filming for her highly anticipated movie Gulabi, a poignant drama that centers around themes ...

In the latest market close, Humacyte, Inc. (HUMA) reached $5.70, with a +0.53% movement compared to the previous day. This change outpaced the S&P 500's 0.76% loss on the day. Meanwhile ...